Bausch + Lomb Corporation (BLCO) is a publicly traded Healthcare sector company. As of August 23, 2026, BLCO trades at $17.25 with a market cap of $6.16B and a P/E ratio of -16.91. BLCO moved +0.23% today. Year to date, BLCO is +0.94%; over the trailing twelve months it is +18.90%. Its 52-week range spans $10.45 to $18.92. Analyst consensus is buy with an average price target of $20.29. Rallies surfaces BLCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for BLCO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $17.25 |
| Market Cap | $6.16B |
| P/E Ratio | -16.91 |
| EPS | $-1.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.92 |
| 52-Week Low | $10.45 |
| Volume | 183.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.10B |
| Net Income | $-352.00M |
| Gross Margin | 0.00% |
9 analysts cover BLCO: 0 strong buy, 4 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.29.